MedPath

Viability of Pulsioflex Monitoring in ICU

Completed
Conditions
Cardiogenic Shock
Interventions
Device: Measurement of the Cardiac Output/ Cardiac Index
Registration Number
NCT04911985
Lead Sponsor
University of Zurich
Brief Summary

Goal of the Study is to Study the precision of semi-invasive cardiac index monitoring by means of the ProAQT (PULSION Medical Systems SE) sensor, whereby the pulmonary artery catheter will serve as gold standard.

Detailed Description

Goal of the Study is to Study the precision of semi-invasive cardiac index monitoring by means of the ProAQT (PULSION Medical Systems SE) sensor, whereby the pulmonary artery catheter will serve as gold standard.

Measurements will be performed contemporaly with both devices every 4 hours and all clinical and hemodynmaic parameters will be recorded, including but not limited to central venous pressure, wege pressure, mechanical ventilation pressures, blood pressures, volume balance as well as vasoaktive medikation doses. This precise evaluation shall serve to evaluate the precision of the ProAQT to estimate the cardiac index under different clinical situation in the intensive care unit. A precision difference of below 30% between both methods will be regarded as clinically irrelevant, suggesting equipoise between both methods.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • In situ pulmonary artery catheter
  • Above 16 years of age
  • At least 36 hours of continuous hemodynamic monitoring with the pulmonary artery catheter planed
Exclusion Criteria
  • Patients with:
  • Permanent or pesisting Atrial Fibrilation or Ventricular Arrythmias
  • Moderate to Severe Aortic Insuficiency or Aortic Stenosis
  • Intravascular Cardiac Assist Device
  • Planed removal of the pulmonary artery catheter <36 hours

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ICU Patients with PACMeasurement of the Cardiac Output/ Cardiac IndexAll patients admitted to the Medical ICU of the University Hospital Zürich, complying with the inclusion criteria and monitored by a pilmonary artery catheter
Primary Outcome Measures
NameTimeMethod
Bias of proAQT measurement51 Hours

Bias between the Pulsion CI measurement and the gold standard CI measurement by Pulmonary artery catheterisation

Secondary Outcome Measures
NameTimeMethod
Percentage Error of CI Measurement51 Hours

Percentage Error of CI Measurement between Pulsion and PAC measurement

Trial Locations

Locations (1)

University Hospital Zurich, Medical intensive care unit

🇨🇭

Zurich, ZH, Switzerland

© Copyright 2025. All Rights Reserved by MedPath